XML 13 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholder's Equity (Details 3) (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Stockholders' Equity    
Stock-based compensation expenses $ 1,574,000 $ 1,388,000
Stock options plans
   
Stockholders' Equity    
Stock-based compensation expenses 1,600,000  
Total unrecognized compensation cost related to non-vested stock options granted (in dollars) 11,300,000  
Period of recognition compensation cost 2 years 7 months 6 days  
Fair value weighted-average assumptions:    
Expected stock price volatility (as a percent) 82.00% 78.40%
Risk free interest rate (as a percent) 1.20% 1.10%
Expected life of options 6 years 3 months 6 years 3 months
Expected annual dividend per share (in dollars per share) $ 0.00 $ 0.00
Number of Shares    
Balance at the beginning of the period (in shares) 7,974,200  
Options granted (in shares) 1,154,500  
Options forfeited (in shares) (47,600)  
Balance at the end of the period (in shares) 9,081,100  
Vested and unvested expected to vest at the end of the period (in shares) 8,012,500  
Exercisable at the end of the period (in shares) 4,450,900  
Weighted Average Exercise Price    
Balance at the beginning of the period (in dollars per share) $ 6.35  
Options granted (in dollars per share) $ 3.53  
Options forfeited (in dollars per share) $ 4.94  
Balance at the end of the period (in dollars per share) $ 5.99  
Vested and unvested expected to vest at the end of the period (in dollars per share) $ 6.10  
Exercisable at the end of the period (in dollars per share) $ 7.25  
Weighted Average Remaining Contractual Life    
Balance at the end of the period 7 years 6 months 4 days  
Vested and unvested expected to vest at the end of the period 7 years 3 months 18 days  
Exercisable at the end of the period 6 years  
Aggregate Intrinsic Value    
Aggregate intrinsic value of options outstanding (in dollars) 207,000  
Aggregate intrinsic value of options vested and unvested expected to vest (in dollars) 132,000  
Aggregate intrinsic value of options exercisable (in dollars) $ 166,000